Trump’s NIH and FDA nominees advance to full Senate vote

Trump’s NIH and FDA nominees advance to full Senate vote


Two of President Donald Trump’s key public health nominations advanced at the committee level Thursday morning, moving them to consideration in the full Senate.

Sen. Bill Cassidy (R-LA), the panel’s chairman, said during the vote that public health in the United States is in a precarious position due to a lack of trust in federal health institutions from failed policies during the COVID-19 pandemic. 

“To start, we need public health leaders committed to transparency and finding unbiased solutions to Americans’ most challenging health problems,” Cassidy said. “Dr. Bhattacharya and Dr. Makary have demonstrated that they are ready to take on this responsibility.”

Trending: California Dems Offer Prayer to a Strange New God to Open Assembly Session

Both Bhattacharya and Makary were grilled by Cassidy in their respective hearings last week on the issue of continuing to fund research

Continue reading


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!